EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Splenic flexure cancer survival: a 25‐year experience and implications for complete mesocolic excision ( CME ) and central vascular ligation ( CVL )

Krishanth Naidu iD, Pierre H Chapuis, Kilian G M Brown, Charles Chan, Matthew J F X Rickard, Kheng-Seong Ng

ANZ Journal of Surgery · 2023

DOI: 10.1111/ans.18434 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift ANZ Journal of Surgery, 2023. Verfasst von Krishanth Naidu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal Surgery Unit, Concord Hospital, Sydney, New South Wales, 2139, Australia. Hauptthemen laut MEDLINE: Colonic Neoplasms, Colon, Transverse, Adenocarcinoma, Mesocolon. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Eric Bishop Research Scholarship (Royal Australasian College of Surgeons), Medtronic Colorectal Research Fellowship (Colorectal Surgical Society of Australia and New Zealand), University of Sydney Senior Lecturer Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The management of splenic flexure cancers (SFCs) in the era of complete mesocolic excision (CME) and central vascular ligation (CVL) is challenging because of its variable lymphatic drainage. This study aimed to compare survival outcomes for SFCs and non‐SFCs, and better understand the clinicopathological characteristics which may define a distinct SFC phenotype.

Methods

An observational cohort study at Concord Hospital, Sydney was conducted with patients who underwent resection for colon adenocarcinoma (1995–2019). Clinicopathological data were extracted from a prospective database. Overall survival (OS) and disease‐free survival (DFS) estimates and their associations to clinicopathological variables were investigated with Kaplan–Meier and Cox regression analyses.

Results

Of 2149 patients with colon cancer, 129 (6%) had an SFC. The overall 5‐year OS and DFS rates were 63.6% (95% CI 62.5–64.7) and 59.4% (95% CI 58.3–60.5), respectively. SFCs were not associated with OS ( P = 0.6) or DFS ( P = 0.5). SFCs were more likely to present urgently ( P < 0.001) with obstruction ( P < 0.001) or perforation ( P = 0.03), and more likely to require an open operation ( P < 0.001). These characteristics were associated with poorer survival outcomes. No differences were noted between SFCs and non‐SFCs with respect to tumour stage ( P = 0.3).

Conclusion

SFCs have a distinct phenotype, the individual characteristics of which are associated with poorer survival. However, the survivals of SFCs and non‐SFCs are similar, possibly because the most important determinant of outcome, tumour stage, is no different between the groups. This may have implications for the surgical approach to SFCs with respect to standardization of CME and CVL surgery for these cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsColon, TransverseAdenocarcinomaMesocolonSplenic NeoplasmsLaparoscopyHumansLigationColectomyLymph Node ExcisionTreatment Outcome

Stichwörter der Autor:innen

CMECVL and splenic flexure cancer

Autor:innen und Institutionen

  • Colorectal Surgery Unit, Concord Hospital, Sydney, New South Wales, 2139, Australia.
  • Concord Institute of Academic Surgery, Concord Hospital, Sydney, New South Wales, 2139, Australia.
  • Concord Clinical School, Clinical Sciences Building, Concord Hospital, University of Sydney, Sydney, New South Wales, 2139, Australia.
  • Department of Anatomical Pathology, Concord Hospital, Sydney, New South Wales, 2139, Australia.

ORCID-Profile: Krishanth Naidu

Förderung

  • Eric Bishop Research Scholarship (Royal Australasian College of Surgeons)
  • Medtronic Colorectal Research Fellowship (Colorectal Surgical Society of Australia and New Zealand)
  • University of Sydney Senior Lecturer Fellowship
  • Royal Australasian College of Surgeons
  • Colorectal Surgical Society of Australia and New Zealand

Zitieren

APA

Naidu, K., Chapuis, P. H., Brown, K. G. M., Chan, C., Rickard, M. J. F. X., & Ng, K. S. (2023). Splenic flexure cancer survival: a 25‐year experience and implications for complete mesocolic excision ( CME ) and central vascular ligation ( CVL ). ANZ Journal of Surgery. https://doi.org/10.1111/ans.18434

Vancouver

Naidu K, Chapuis PH, Brown KGM, Chan C, Rickard MJFX, Ng KS. Splenic flexure cancer survival: a 25‐year experience and implications for complete mesocolic excision ( CME ) and central vascular ligation ( CVL ). ANZ Journal of Surgery. 2023. doi:10.1111/ans.18434

BibTeX
@article{Naidu2023,
  author = {Naidu, Krishanth and Chapuis, Pierre H and Brown, Kilian G M and Chan, Charles and Rickard, Matthew J F X and Ng, Kheng-Seong},
  title = {Splenic flexure cancer survival: a 25‐year experience and implications for complete mesocolic excision ( CME ) and central vascular ligation ( CVL )},
  journal = {ANZ Journal of Surgery},
  year = {2023},
  doi = {10.1111/ans.18434}
}
Kostenlos starten →